ACADIA PHARMACEUTICALS INC
ACAD
26 insider filings · Latest: Jun 26, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| May 16, 2025 | May 16 9:06 PM | Kihara James | Proposed Sale | 4,000 | $17.60 | $70.4K | — | View → |
| Mar 5, 2025 | Mar 6 5:17 PM | GAROFALO ELIZABETH A. | Proposed Sale | 4,919 | $18.23 | $89.7K | — | View → |
← Previous
Page 2 of 2
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| May 29, 2026 | Jun 2 8:32 PM | BAKER BROS. ADVISORS LPDirector, 10% Owner | Grant/Award | 64,016 | $21.66 | 32,008(I) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Edmund HarriganDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Adora NduDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Laura BregeDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Option Exercise | 2,010 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Jonathan PooleDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | Elizabeth A. GarofaloDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Option Exercise | 8,107 | — | 0(D) | View → |
| May 29, 2026 | Jun 1 10:00 PM | James M DalyDirector | Grant/Award | 25,315 | $21.66 | 9,311(D) | View → |
| May 1, 2026 | May 5 10:00 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,596 | — | 2,596(D) | View → |
| May 1, 2026 | May 5 10:00 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 6,815 | — | 6,815(D) | View → |
| Apr 5, 2026 | Apr 7 11:57 PM | Mark C. SchneyerEVP, CHIEF FINANCIAL OFFICER | Option Exercise | 5,276 | — | 0(D) | View → |
| Apr 5, 2026 | Apr 7 11:55 PM | James KiharaPRINCIPAL ACCOUNTING OFFICER | Option Exercise | 2,010 | — | 0(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Adams Catherine OwenDirector, Chief Executive Officer | Option Exercise | 23,509 | — | 70,530(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Jennifer J RhodesEVP, CHIEF LEGAL OFFICER, SEC | Option Exercise | 7,515 | — | 22,547(D) | View → |
| Mar 24, 2026 | Mar 27 12:00 AM | Elizabeth H.Z. ThompsonEVP, Head of Research & Dev | Option Exercise | 6,715 | — | 20,146(D) | View → |
Page 1 of 2
Next →